Based on previous studies investigating the role of BAK1, FIS1, and SFN, one primary function of these three genes in Barrett’s esophagus and in Barrett’s associated OAC may also be in conferring therapeutic resistance to cells; however, further studies are necessary to explore this relationship. The gene discussed is BAK1; the disease is esophageal adenocarcinoma.